These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 10902788)

  • 1. Home capillary sampling and screening for type 1 diabetes, celiac disease, and autoimmune thyroid disease in a Swedish general pediatric population: the TRIAD study.
    Naredi Scherman M; Lind A; Hamdan S; Lundgren M; Svensson J; Pociot F; Agardh D
    Front Pediatr; 2024; 12():1386513. PubMed ID: 38699153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody-Positive Individuals.
    So M; O'Rourke C; Bahnson HT; Greenbaum CJ; Speake C
    Diabetes Care; 2020 Apr; 43(4):913-917. PubMed ID: 32019856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of glutamine and phospholipids levels in first degree relatives of patients with Type 1 Diabetes from a multiethnic population.
    Araujo de Pina Cabral DB; Dantas JR; Skärstrand H; Barone B; Carvalho F; Tortora R; Milech A; Vaziri-Sani F; Oliveira JE; Zajdenverg L; Rodacki M
    Diabetol Metab Syndr; 2015; 7():52. PubMed ID: 26082806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetes.
    Levy H; Wang X; Kaldunski M; Jia S; Kramer J; Pavletich SJ; Reske M; Gessel T; Yassai M; Quasney MW; Dahmer MK; Gorski J; Hessner MJ
    Genes Immun; 2012 Dec; 13(8):593-604. PubMed ID: 22972474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age.
    Vermeulen I; Weets I; Costa O; Asanghanwa M; Verhaeghen K; Decochez K; Ruige J; Casteels K; Wenzlau J; Hutton JC; Pipeleers DG; Gorus FK;
    Diabetologia; 2012 Feb; 55(2):413-20. PubMed ID: 22095238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction and pathogenesis in type 1 diabetes.
    Ziegler AG; Nepom GT
    Immunity; 2010 Apr; 32(4):468-78. PubMed ID: 20412757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between blocking folate receptor autoantibodies and subfertility.
    Berrocal-Zaragoza MI; Fernandez-Ballart JD; Murphy MM; Cavallé-Busquets P; Sequeira JM; Quadros EV
    Fertil Steril; 2009 Apr; 91(4 Suppl):1518-21. PubMed ID: 18950755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prediabetes in first-degree relatives at intermediate risk of type I diabetes.
    Truyen I; De Grijse J; Weets I; Kaufman L; Pipeleers L; Nanos N; Decochez K; Hilbrands R; Kaufman JM; Keymeulen B; Mathieu C; Van Gaal L; Pipeleers DG; Gorus FK;
    Clin Exp Immunol; 2007 Aug; 149(2):243-50. PubMed ID: 17521324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinsulin levels and the proinsulin:c-peptide ratio complement autoantibody measurement for predicting type 1 diabetes.
    Truyen I; De Pauw P; Jørgensen PN; Van Schravendijk C; Ubani O; Decochez K; Vandemeulebroucke E; Weets I; Mao R; Pipeleers DG; Gorus FK;
    Diabetologia; 2005 Nov; 48(11):2322-9. PubMed ID: 16211374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting type 1 diabetes.
    Achenbach P; Bonifacio E; Ziegler AG
    Curr Diab Rep; 2005 Apr; 5(2):98-103. PubMed ID: 15794911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.
    Decochez K; Truyen I; van der Auwera B; Weets I; Vandemeulebroucke E; de Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Pipeleers DG; Gorus FK;
    Diabetologia; 2005 Apr; 48(4):687-94. PubMed ID: 15756536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity.
    Walter M; Albert E; Conrad M; Keller E; Hummel M; Ferber K; Barratt BJ; Todd JA; Ziegler AG; Bonifacio E
    Diabetologia; 2003 May; 46(5):712-20. PubMed ID: 12750767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity and familial risk of type 1 diabetes.
    Hämäläinen AM; Knip M
    Curr Diab Rep; 2002 Aug; 2(4):347-53. PubMed ID: 12643195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient antiislet autoantibodies: infrequent occurrence and lack of association with "genetic" risk factors.
    Yu J; Yu L; Bugawan TL; Erlich HA; Barriga K; Hoffman M; Rewers M; Eisenbarth GS
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2421-8. PubMed ID: 10902788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygosity for premature stop codon of the MHC class I chain-related gene A (MIC-A) is associated with early activation of islet autoimmunity of DR3/4-DQ2/8 high risk DAISY relatives.
    Ide A; Babu SR; Robles DT; Wang T; Erlich HA; Bugawan TL; Rewers M; Fain PR; Eisenbarth GS
    J Clin Immunol; 2005 Jul; 25(4):303-8. PubMed ID: 16133985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported lower respiratory tract infections and development of islet autoimmunity in children with the type 1 diabetes high-risk HLA genotype: the MIDIA study.
    Rasmussen T; Witsø E; Tapia G; Stene LC; Rønningen KS
    Diabetes Metab Res Rev; 2011 Nov; 27(8):834-7. PubMed ID: 22069269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
    Barker JM; Barriga KJ; Yu L; Miao D; Erlich HA; Norris JM; Eisenbarth GS; Rewers M;
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3896-902. PubMed ID: 15292324
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.